- Previous Close
19.09 - Open
19.16 - Bid --
- Ask --
- Day's Range
19.16 - 19.56 - 52 Week Range
16.84 - 24.94 - Volume
24,318 - Avg. Volume
46,637 - Market Cap (intraday)
990.058M - Beta (5Y Monthly) --
- PE Ratio (TTM)
84.77 - EPS (TTM)
0.23 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
27.50
Exosens engages in the development, manufacture, and sale of electro-optical technologies in the fields of amplification, and detection and imaging in France, rest of Europe, North America, Asia, Oceania, Africa, and internationally. It offers image intensifier tubes; ultra violet, short and long wave infrared, visible - near infrared, and mid wave infrared cameras, as well as enhanced vision equipment; ion and electron, scintillation, and single photon detection products; x-ray components, neutronic imaging products, and image intensifiers for scientific applications; and gamma and neutron detectors, and mineral insulated extensions. The company also provides power tubes and microwave devices; and methane airborne detection solutions. It operates under the Photonis, Xenics, Telops, and El-Mul brand names. The company serves defense and surveillance, industrial research and control, life science and environment, and nuclear markets. The company was founded in 1937 and is based in Mérignac, France. Exosens operates as a subsidiary of HLD Europe S.C.A.
www.exosens.com1,600
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: EXENS.PA
View MorePerformance Overview: EXENS.PA
Trailing total returns as of 12/27/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: EXENS.PA
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: EXENS.PA
View MoreValuation Measures
Market Cap
969.44M
Enterprise Value
1.10B
Trailing P/E
82.10
Forward P/E
12.32
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.55
Price/Book (mrq)
2.54
Enterprise Value/Revenue
2.90
Enterprise Value/EBITDA
11.12
Financial Highlights
Profitability and Income Statement
Profit Margin
3.68%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
353.72M
Net Income Avi to Common (ttm)
1.95M
Diluted EPS (ttm)
0.23
Balance Sheet and Cash Flow
Total Cash (mrq)
123.2M
Total Debt/Equity (mrq)
68.22%
Levered Free Cash Flow (ttm)
--